The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: Lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 2, 2012, Pages 632-637

  Long, Anna E ^a   Gooneratne, A Talia ^a   Rokni, Saba ^a   Williams, Alistair J K ^a   Bingley, Polly J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN; INSULIN ANTIBODY; ISLET ANTIGEN 2 ANTIBODY; ISLET ANTIGEN 2BETA ANTIBODY; NICOTINAMIDE; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG; ZINC TRANSPORTER 8 ANTIBODY;

ACCURACY; ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOLLOW UP; GENETIC RISK; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RELATIVE; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; ADULT; AUTOANTIBODIES; CATION TRANSPORT PROTEINS; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIAGNOSTIC TECHNIQUES, ENDOCRINE; EUROPE; FAMILY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NIACINAMIDE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 84856775181     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1952     Document Type: Article

References (15)

1. Bingley PJ 2010 Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 95:25-33
2. Achenbach P, Bonifacio E, Williams AJ, Ziegler AG, Gale EA, Bingley PJ 2008 Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives. Diabetologia 51:488-492
3. Bingley PJ, Gale EA 2006 Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia 49:881-890
4. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC 2007 The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 104:17040-17045 (Pubitemid 350210987)
5. Wenzlau JM, Frisch LM, Gardner TJ, Sarkar S, Hutton JC, Davidson HW 2009 Novel antigens in type 1 diabetes: the importance of ZnT8. Curr Diab Rep 9:105-112
6. De Grijse J, Asanghanwa M, Nouthe B, Albrecher N, Goubert P, Vermeulen I, Van Der Meeren S, Decochez K, Weets I, Keymeulen B, Lampasona V, Wenzlau J, Hutton JC, Pipeleers D, Gorus FK 2010 Predictive power of screening for antibodies against insulinoma-associated protein 2 β (IA-2β) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia 53:517-524
7. Vermeulen I, Weets I, Asanghanwa M, Ruige J, Van Gaal L, Mathieu C, Keymeulen B, Lampasona V, Wenzlau JM, Hutton JC, Pipeleers DG, Gorus FK 2011 Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age. Diabetes Care 34:1760-1765
8. The European Nicotinamide Diabetes Intervention Trial Group 2003 Intervening before the onset of type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetologia 46:339-346
9. European Nicotinamide Diabetes Intervention Trial (ENDIT) Group 2004 European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925-931
10. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA 1997 Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710 (Pubitemid 27456400)
11. Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA 1997 A novel micro-assay for insulin autoantibodies. J Autoimmun 10:473-478 (Pubitemid 27433643)
12. Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H, Winkler C, Pflüger M, Illig T, Bonifacio E, Ziegler AG 2009 Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 52:1881-1888
13. Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, di Pietro S, Songini M, Bonicchio S, Giorgino F, Bonifacio E, Bosi E, Buzzetti R 2010 Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care 33:104-108
14. Vardi P, Ziegler AG, Mathews JH, Dib S, Keller RJ, Ricker AT, Wolfsdorf JI, Herskowitz RD, Rabizadeh A, Eisenbarth GS, Soeldner JS 1988 Concentration of insulin autoantibodies at onset of type 1 diabetes. Inverse log-linear correlation with age. Diabetes Care 11:736-739
15. Gillespie KM, Bain SC, Barnett AH, Bingley PJ, Christie MR, Gill GV, Gale EA 2004 The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364:1699-1700 (Pubitemid 39458146)